Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated:  3/18/2016
Clinical Research Facility
mi
from
Nashville, TN
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated: 3/18/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated:  3/18/2016
Clinical Research Facility
mi
from
Fort Worth, TX
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated: 3/18/2016
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated:  3/18/2016
Clinical Research Facility
mi
from
Fort Worth, TX
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated: 3/18/2016
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated:  3/18/2016
Clinical Research Facility
mi
from
Fort Worth, TX
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated: 3/18/2016
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated:  3/18/2016
Clinical Research Facility
mi
from
Grand Prairie, TX
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated: 3/18/2016
Clinical Research Facility
mi
from
Grand Prairie, TX
Click here to add this to my saved trials
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated:  3/18/2016
Clinical Research Facility
mi
from
Houston, TX
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated: 3/18/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated:  3/18/2016
Clinical Research Facility
mi
from
Houston, TX
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated: 3/18/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated:  3/18/2016
Clinical Research Facility
mi
from
Mansfield, TX
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated: 3/18/2016
Clinical Research Facility
mi
from
Mansfield, TX
Click here to add this to my saved trials
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated:  3/18/2016
Clinical Research Facility
mi
from
San Antonio, TX
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated: 3/18/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated:  3/18/2016
Clinical Research Facility
mi
from
San Antonio, TX
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated: 3/18/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated:  3/18/2016
Clinical Research Facility
mi
from
San Antonio, TX
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated: 3/18/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated:  3/18/2016
Clinical Research Facility
mi
from
San Antonio, TX
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated: 3/18/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated:  3/18/2016
Clinical Research Facility
mi
from
Morgantown, WV
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated: 3/18/2016
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated:  3/18/2016
mi
from
Muroran,
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A Randomized, Parallel Group, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Maintenance Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis and on Treatment With an Erythropoiesis-stimulating Agent in the United States and Japan
Status: Enrolling
Updated: 3/18/2016
mi
from
Muroran,
Click here to add this to my saved trials
Empowering Patients On Choices for Renal Replacement Therapy (Aim 1)
Empowering Patients On Choices for Renal Replacement Therapy (Aim 1)
Status: Enrolling
Updated:  3/21/2016
Arbor Research Collaborative for Health
mi
from
Ann Arbor, MI
Empowering Patients On Choices for Renal Replacement Therapy (Aim 1)
Empowering Patients On Choices for Renal Replacement Therapy (Aim 1)
Status: Enrolling
Updated: 3/21/2016
Arbor Research Collaborative for Health
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Blood Volume Analysis and Renal Outcomes in Hemodialysis
Blood Volume Analysis and Renal Outcomes in Hemodialysis
Status: Enrolling
Updated:  3/22/2016
New York Harbor VA Healthcare System Hemodialysis Unit
mi
from
New York, NY
Blood Volume Analysis and Renal Outcomes in Hemodialysis
Blood Volume Analysis and Renal Outcomes in Hemodialysis
Status: Enrolling
Updated: 3/22/2016
New York Harbor VA Healthcare System Hemodialysis Unit
mi
from
New York, NY
Click here to add this to my saved trials
Vasodilators and Anti-Oxidant Therapy in Early ATN
Combination Fenoldopam Mesylate and Intravenous MESNA (2-mercaptoethane Sulphonate)in Early Acute Kidney Injury (AKD): A Randomized, Double-Blind Placebo Controlled Clinical Trial
Status: Enrolling
Updated:  3/25/2016
Mandeep Grewal
mi
from
Chattanooga, TN
Vasodilators and Anti-Oxidant Therapy in Early ATN
Combination Fenoldopam Mesylate and Intravenous MESNA (2-mercaptoethane Sulphonate)in Early Acute Kidney Injury (AKD): A Randomized, Double-Blind Placebo Controlled Clinical Trial
Status: Enrolling
Updated: 3/25/2016
Mandeep Grewal
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Vasodilators and Anti-Oxidant Therapy in Early ATN
Combination Fenoldopam Mesylate and Intravenous MESNA (2-mercaptoethane Sulphonate)in Early Acute Kidney Injury (AKD): A Randomized, Double-Blind Placebo Controlled Clinical Trial
Status: Enrolling
Updated:  3/25/2016
Chawala, M. MD
mi
from
Washington,
Vasodilators and Anti-Oxidant Therapy in Early ATN
Combination Fenoldopam Mesylate and Intravenous MESNA (2-mercaptoethane Sulphonate)in Early Acute Kidney Injury (AKD): A Randomized, Double-Blind Placebo Controlled Clinical Trial
Status: Enrolling
Updated: 3/25/2016
Chawala, M. MD
mi
from
Washington,
Click here to add this to my saved trials
Vitamin D and Carboxy PTH Fragments in Coronary Calcification
A Prospective, Randomized, Open-Label Trial Investigating the Effect of 1 Alpha Hydroxy Vitamin D2 on the Development of Coronary Calcification in New ESRD Patients Using the 1-84/7-84 PTH Ratio to Determine Dosing
Status: Enrolling
Updated:  3/25/2016
Davita East Charlotte Dialysis Unit
mi
from
Charlotte, NC
Vitamin D and Carboxy PTH Fragments in Coronary Calcification
A Prospective, Randomized, Open-Label Trial Investigating the Effect of 1 Alpha Hydroxy Vitamin D2 on the Development of Coronary Calcification in New ESRD Patients Using the 1-84/7-84 PTH Ratio to Determine Dosing
Status: Enrolling
Updated: 3/25/2016
Davita East Charlotte Dialysis Unit
mi
from
Charlotte, NC
Click here to add this to my saved trials
Intra-Renal Therapy of Diuretic Unresponsive Acute Kidney Injury
Effect of Combination Intra-Renal Infusion of Fenoldopam Mesylate and High Dose Diuretics on Peak Serum Creatinine and Incidence of Renal Replacement Therapy in Patients With Early Acute Kidney Injury
Status: Enrolling
Updated:  3/25/2016
Erlanger Medical Center
mi
from
Chattanooga, TN
Intra-Renal Therapy of Diuretic Unresponsive Acute Kidney Injury
Effect of Combination Intra-Renal Infusion of Fenoldopam Mesylate and High Dose Diuretics on Peak Serum Creatinine and Incidence of Renal Replacement Therapy in Patients With Early Acute Kidney Injury
Status: Enrolling
Updated: 3/25/2016
Erlanger Medical Center
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5
Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5
Status: Enrolling
Updated:  3/25/2016
University of Michigan Hospital
mi
from
Ann Arbor, MI
Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5
Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5
Status: Enrolling
Updated: 3/25/2016
University of Michigan Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Healthy Transitions in Late Stage Kidney Disease
An Open Label Randomized Controlled Study to Compare the Impact of Patient Centered Nursing Services in Addition to a Nephrologist's Usual Patient Care With Usual Nephrologist's Care in Late Stage Chronic Kidney Disease Patients.
Status: Enrolling
Updated:  3/30/2016
Division of Kidney diseases and Hypertension
mi
from
Great Neck, NY
Healthy Transitions in Late Stage Kidney Disease
An Open Label Randomized Controlled Study to Compare the Impact of Patient Centered Nursing Services in Addition to a Nephrologist's Usual Patient Care With Usual Nephrologist's Care in Late Stage Chronic Kidney Disease Patients.
Status: Enrolling
Updated: 3/30/2016
Division of Kidney diseases and Hypertension
mi
from
Great Neck, NY
Click here to add this to my saved trials
Medication Intervention in Transitional Care to Optimize Outcomes & Costs for CKD & ESRD
Medication Intervention in Transitional Care to Optimize Outcomes & Costs in CKD & ESRD
Status: Enrolling
Updated:  3/31/2016
Providence Sacred Heart Medical Center & Children's Hospital
mi
from
Spokane, WA
Medication Intervention in Transitional Care to Optimize Outcomes & Costs for CKD & ESRD
Medication Intervention in Transitional Care to Optimize Outcomes & Costs in CKD & ESRD
Status: Enrolling
Updated: 3/31/2016
Providence Sacred Heart Medical Center & Children's Hospital
mi
from
Spokane, WA
Click here to add this to my saved trials
Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function
Modifiable Effectors of Renin System Activation: Treatment Evaluation (MODERATE)
Status: Enrolling
Updated:  4/1/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function
Modifiable Effectors of Renin System Activation: Treatment Evaluation (MODERATE)
Status: Enrolling
Updated: 4/1/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Sodium Bicarbonate in Kidney Transplant Recipients
Randomized Trial of Sodium Bicarbonate in Renal Transplant Recipients With Low-normal Serum Bicarbonate Levels
Status: Enrolling
Updated:  4/5/2016
University of Utah
mi
from
Salt Lake City, UT
Study of Sodium Bicarbonate in Kidney Transplant Recipients
Randomized Trial of Sodium Bicarbonate in Renal Transplant Recipients With Low-normal Serum Bicarbonate Levels
Status: Enrolling
Updated: 4/5/2016
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Matrix Metalloproteinases and Diabetic Nephropathy
Matrix Metalloproteinases and Diabetic Nephropathy
Status: Enrolling
Updated:  4/12/2016
Arkansas Children's Hospital/University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Matrix Metalloproteinases and Diabetic Nephropathy
Matrix Metalloproteinases and Diabetic Nephropathy
Status: Enrolling
Updated: 4/12/2016
Arkansas Children's Hospital/University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Functional and Cognitive Impairment in Advanced Kidney Disease
Functional and Cognitive Impairment in Advanced Kidney Disease
Status: Enrolling
Updated:  4/13/2016
James J. Peters VA Medical Center, Bronx, NY
mi
from
Bronx, NY
Functional and Cognitive Impairment in Advanced Kidney Disease
Functional and Cognitive Impairment in Advanced Kidney Disease
Status: Enrolling
Updated: 4/13/2016
James J. Peters VA Medical Center, Bronx, NY
mi
from
Bronx, NY
Click here to add this to my saved trials
Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease
A Phase 1, Open-label Study to Evaluate the Effect of Lapatinib, a BCRP Inhibitor, on the Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease Receiving Hemodialysis
Status: Enrolling
Updated:  4/27/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease
A Phase 1, Open-label Study to Evaluate the Effect of Lapatinib, a BCRP Inhibitor, on the Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease Receiving Hemodialysis
Status: Enrolling
Updated: 4/27/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
PK and PD of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects
A Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects
Status: Enrolling
Updated:  5/2/2016
Jasper Clinical Research & Development, Inc.
mi
from
Kalamazoo, MI
PK and PD of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects
A Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects
Status: Enrolling
Updated: 5/2/2016
Jasper Clinical Research & Development, Inc.
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males
An Open-label Exploratory Study of the Pharmacokinetic Interaction of CXA-10 Administered to Steady State With Pravastatin and Vytorin® (Simvastatin and Ezetimibe) in Healthy Males
Status: Enrolling
Updated:  5/2/2016
Jasper Clinical Research & Development, Inc.
mi
from
Kalamazoo, MI
A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males
An Open-label Exploratory Study of the Pharmacokinetic Interaction of CXA-10 Administered to Steady State With Pravastatin and Vytorin® (Simvastatin and Ezetimibe) in Healthy Males
Status: Enrolling
Updated: 5/2/2016
Jasper Clinical Research & Development, Inc.
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
A Pharmacokinetics and Safety Study in Subjects With Renal Impairment
A Phase I Open-Label Study With 200 mg Intravenous TR-701 Free Acid to Assess Safety and Pharmacokinetics in Advanced Renal Impairment Subjects
Status: Enrolling
Updated:  5/2/2016
Trius Investigator Site 001
mi
from
Orlando, FL
A Pharmacokinetics and Safety Study in Subjects With Renal Impairment
A Phase I Open-Label Study With 200 mg Intravenous TR-701 Free Acid to Assess Safety and Pharmacokinetics in Advanced Renal Impairment Subjects
Status: Enrolling
Updated: 5/2/2016
Trius Investigator Site 001
mi
from
Orlando, FL
Click here to add this to my saved trials
A Pharmacokinetics and Safety Study in Subjects With Renal Impairment
A Phase I Open-Label Study With 200 mg Intravenous TR-701 Free Acid to Assess Safety and Pharmacokinetics in Advanced Renal Impairment Subjects
Status: Enrolling
Updated:  5/2/2016
Trius investigator site 153
mi
from
Minneapolis, MN
A Pharmacokinetics and Safety Study in Subjects With Renal Impairment
A Phase I Open-Label Study With 200 mg Intravenous TR-701 Free Acid to Assess Safety and Pharmacokinetics in Advanced Renal Impairment Subjects
Status: Enrolling
Updated: 5/2/2016
Trius investigator site 153
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Delayed Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion
Delayed Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion
Status: Enrolling
Updated:  5/10/2016
Northwestern Memorial Hospital
mi
from
Chicago, IL
Delayed Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion
Delayed Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion
Status: Enrolling
Updated: 5/10/2016
Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Heart Care Research, LLC
mi
from
Huntsville, AL
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Heart Care Research, LLC
mi
from
Huntsville, AL
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
St. Luke's Medical Center
mi
from
Phoenix, AZ
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
St. Luke's Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Kaiser Permanente
mi
from
Los Angeles, CA
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Kaiser Permanente
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Stanford Hospitals and Clinics
mi
from
Stanford, CA
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Stanford Hospitals and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Harbor-UCLA
mi
from
Torrance, CA
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Harbor-UCLA
mi
from
Torrance, CA
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
The Heart & Vascular Institute Of Florida
mi
from
Clearwater, FL
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
The Heart & Vascular Institute Of Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Infinity Clinical Research, LLC
mi
from
Hollywood, FL
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Infinity Clinical Research, LLC
mi
from
Hollywood, FL
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Saint Joseph's Hospital of Atlanta
mi
from
Atlanta, GA
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Saint Joseph's Hospital of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Franciscan St. Francis Health, Site
mi
from
Indianapolis, IN
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Franciscan St. Francis Health, Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
St. Mary's Medical Center
mi
from
Duluth, MN
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
St. Mary's Medical Center
mi
from
Duluth, MN
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Elyria Memorial Hospital Medical Center
mi
from
Elyria, OH
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Elyria Memorial Hospital Medical Center
mi
from
Elyria, OH
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Oklahoma Foundation for Cardiovascular Research
mi
from
Oklahoma City, OK
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Oklahoma Foundation for Cardiovascular Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
South Carolina Heart Center
mi
from
Columbia, SC
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
South Carolina Heart Center
mi
from
Columbia, SC
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Greenville Health System
mi
from
Greenville, SC
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Greenville Health System
mi
from
Greenville, SC
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Tennova Healthcare - Turkey Creek Medical Center
mi
from
Knoxville, TN
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Tennova Healthcare - Turkey Creek Medical Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
The Methodist Hospital of Research
mi
from
Houston, TX
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
The Methodist Hospital of Research
mi
from
Houston, TX
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Cardiovascular Associates of East Texas, P.A.
mi
from
Tyler, TX
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Cardiovascular Associates of East Texas, P.A.
mi
from
Tyler, TX
Click here to add this to my saved trials